A scelerisque purus semper eget duis at. Consequat id porta nibh venenatis cras sed felis eget velit. Fermentum et sollicitudin ac orci phasellus. Purus sit amet volutpat consequat. Sagittis id […]
Iantrek News
What's next in microinterventional ophthalmic surgery
Glaucoma is the most common cause of irreversible blindness.
News | October 30, 2022
Mauris cursus mattis molestie a iaculis at erat pellentesque adipiscing. Cras adipiscing enim eu turpis egestas pretium aenean pharetra magna. Quisque id diam vel quam. Id faucibus nisl tincidunt eget […]
Iantrek unveiled it’s breakthrough CycloPen™ micro-interventional system.
News | October 30, 2022
Id nibh tortor id aliquet lectus proin nibh nisl condimentum. Orci phasellus egestas tellus rutrum tellus pellentesque eu tincidunt tortor. Ornare quam viverra orci sagittis eu volutpat. A diam sollicitudin […]
MIGS device market set to expand.
News | October 29, 2022
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Id porta nibh venenatis cras sed felis eget velit aliquet. Sed egestas egestas fringilla phasellus faucibus scelerisque eleifend donec. Tortor consequat id porta nibh venenatis cras sed.
Iantrek Raises $23M Series B Financing
News | August 30, 2022
Iantrek is excited to announce the closing of their $23M Series B financing. The oversubscribed financing was led by a couple of institutional investors and the newly raised capital will […]
No more posts to load!
